These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 8234141)
21. How selective are the cholecystokinin antagonists in the dog? Fox-Threlkeld JA; Daniel EE Gastroenterology; 1995 Jun; 108(6):1953-5. PubMed ID: 7768405 [No Abstract] [Full Text] [Related]
23. Revised NMR assignments for the cholecystokinin antagonist asperlicin. Sun HH; Byard SJ; Cooper R J Antibiot (Tokyo); 1994 May; 47(5):599-601. PubMed ID: 8040060 [No Abstract] [Full Text] [Related]
24. Cholecystokinin receptors and animal models of anxiety. Harro J; Oreland L; Vasar E Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():479A-480A. PubMed ID: 1498919 [No Abstract] [Full Text] [Related]
25. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey. Dourish CT; O'Neill MF; Schaffer LW; Siegl PK; Iversen SD J Pharmacol Exp Ther; 1990 Dec; 255(3):1158-65. PubMed ID: 2262899 [TBL] [Abstract][Full Text] [Related]
26. Molecular modelling of asperlicin derived cholecystokinin A receptor antagonists. Van der Bent A; Ter Laak AM; IJzerman AP; Soudijn W Eur J Pharmacol; 1992 Aug; 226(4):327-34. PubMed ID: 1397061 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area. Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of cholecystokinin receptor antagonists in CNS disorders. Schiantarelli P Pharmacol Res; 1993; 28(1):1-9. PubMed ID: 8234141 [No Abstract] [Full Text] [Related]
29. [Cholecystokinin antagonists: anxiolytic drugs of the future]. Bourin M; Bradwejn J Pathol Biol (Paris); 1992 Mar; 40(3):215-7. PubMed ID: 1608663 [No Abstract] [Full Text] [Related]
30. [Cholecystokinin and its antagonists: effects on digestive motility]. Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015 [No Abstract] [Full Text] [Related]
31. [Receptor agonists and antagonists: the present and future]. Tanaka H Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1813-26. PubMed ID: 8210427 [No Abstract] [Full Text] [Related]
32. Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications. Iversen LL; Dourish CT; Iversen SD Biochem Soc Trans; 1991 Nov; 19(4):913-5. PubMed ID: 1794582 [No Abstract] [Full Text] [Related]